Suppr超能文献

相似文献

2
Accumulation of ubiquitin conjugates in a polyglutamine disease model occurs without global ubiquitin/proteasome system impairment.
Proc Natl Acad Sci U S A. 2009 Aug 18;106(33):13986-91. doi: 10.1073/pnas.0906463106. Epub 2009 Jul 30.
3
Dynamic recruitment of active proteasomes into polyglutamine initiated inclusion bodies.
FEBS Lett. 2014 Jan 3;588(1):151-9. doi: 10.1016/j.febslet.2013.11.023. Epub 2013 Nov 26.
5
Global changes to the ubiquitin system in Huntington's disease.
Nature. 2007 Aug 9;448(7154):704-8. doi: 10.1038/nature06022.
7
Single neuron ubiquitin-proteasome dynamics accompanying inclusion body formation in huntington disease.
J Biol Chem. 2009 Feb 13;284(7):4398-403. doi: 10.1074/jbc.M806269200. Epub 2008 Dec 10.
8
Inhibiting the ubiquitin-proteasome system leads to preferential accumulation of toxic N-terminal mutant huntingtin fragments.
Hum Mol Genet. 2010 Jun 15;19(12):2445-55. doi: 10.1093/hmg/ddq127. Epub 2010 Mar 30.
10
Impaired ubiquitin-proteasome system activity in the synapses of Huntington's disease mice.
J Cell Biol. 2008 Mar 24;180(6):1177-89. doi: 10.1083/jcb.200709080.

引用本文的文献

1
Pin1-Catalyzed Conformation Changes Regulate Protein Ubiquitination and Degradation.
Cells. 2024 Apr 23;13(9):731. doi: 10.3390/cells13090731.
2
The Emerging Landscape of Natural Small-molecule Therapeutics for Huntington's Disease.
Curr Neuropharmacol. 2023;21(4):867-889. doi: 10.2174/1570159X21666230216104621.
3
Reduction in PA28αβ activation in HD mouse brain correlates to increased mHTT aggregation in cell models.
PLoS One. 2022 Dec 27;17(12):e0278130. doi: 10.1371/journal.pone.0278130. eCollection 2022.
4
Cytosolic stress granules relieve the ubiquitin-proteasome system in the nuclear compartment.
EMBO J. 2023 Feb 1;42(3):e111802. doi: 10.15252/embj.2022111802. Epub 2022 Dec 27.
5
Altered Cholesterol Homeostasis in Huntington's Disease.
Front Aging Neurosci. 2022 Apr 19;14:797220. doi: 10.3389/fnagi.2022.797220. eCollection 2022.
6
Passive immunization against phosphorylated tau improves features of Huntington's disease pathology.
Mol Ther. 2022 Apr 6;30(4):1500-1522. doi: 10.1016/j.ymthe.2022.01.020. Epub 2022 Jan 17.
7
Fluc-EGFP reporter mice reveal differential alterations of neuronal proteostasis in aging and disease.
EMBO J. 2021 Oct 1;40(19):e107260. doi: 10.15252/embj.2020107260. Epub 2021 Aug 19.
9
Neuron type-specific increase in lamin B1 contributes to nuclear dysfunction in Huntington's disease.
EMBO Mol Med. 2021 Feb 5;13(2):e12105. doi: 10.15252/emmm.202012105. Epub 2020 Dec 28.
10
Targeting Tau to Treat Clinical Features of Huntington's Disease.
Front Neurol. 2020 Nov 19;11:580732. doi: 10.3389/fneur.2020.580732. eCollection 2020.

本文引用的文献

2
Accumulation of ubiquitin conjugates in a polyglutamine disease model occurs without global ubiquitin/proteasome system impairment.
Proc Natl Acad Sci U S A. 2009 Aug 18;106(33):13986-91. doi: 10.1073/pnas.0906463106. Epub 2009 Jul 30.
3
A critical evaluation of the ubiquitin-proteasome system in Parkinson's disease.
Biochim Biophys Acta. 2009 Jul;1792(7):664-75. doi: 10.1016/j.bbadis.2009.01.012. Epub 2009 Feb 3.
5
Single neuron ubiquitin-proteasome dynamics accompanying inclusion body formation in huntington disease.
J Biol Chem. 2009 Feb 13;284(7):4398-403. doi: 10.1074/jbc.M806269200. Epub 2008 Dec 10.
7
Impaired ERAD and ER stress are early and specific events in polyglutamine toxicity.
Genes Dev. 2008 Dec 1;22(23):3308-19. doi: 10.1101/gad.1673408. Epub 2008 Nov 17.
10
A common motif targets huntingtin and the androgen receptor to the proteasome.
J Biol Chem. 2008 Aug 29;283(35):23950-5. doi: 10.1074/jbc.M800467200. Epub 2008 Jun 27.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验